HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

Shabnum Patel; Ryo Hanajiri; Melanie Grant; Devin Saunders; Stacey Van Pelt; Michael Keller; Patrick J. Hanley; Gary Simon; Douglas F. Nixon; David Hardy; R. Brad Jones; Catherine M. Bollard

doi:10.1016/j.omtm.2019.10.001

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

Shabnum Patel
, Ryo Hanajiri
, Melanie Grant
, Devin Saunders
, Stacey Van Pelt
, Michael Keller
, Patrick J. Hanley
, Gary Simon
, Douglas F. Nixon
, David Hardy
, R. Brad Jones
, Catherine M. Bollard

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	11-20
Number of pages	10
Journal	Molecular Therapy Methods and Clinical Development
Volume	16
DOIs	https://doi.org/10.1016/j.omtm.2019.10.001
State	Published - Mar 13 2020
Externally published	Yes

ASJC Scopus Subject Areas

Molecular Medicine
Molecular Biology
Genetics

Keywords

conserved epitopes
HIV-specific T cells
immunotherapy
latent reservoir
viral escape

Access to Document

10.1016/j.omtm.2019.10.001

Cite this

Patel, S., Hanajiri, R., Grant, M., Saunders, D., Van Pelt, S., Keller, M., Hanley, P. J., Simon, G., Nixon, D. F., Hardy, D., Jones, R. B., & Bollard, C. M. (2020). HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform. Molecular Therapy Methods and Clinical Development, 16, 11-20. https://doi.org/10.1016/j.omtm.2019.10.001

Patel, S, Hanajiri, R, Grant, M, Saunders, D, Van Pelt, S, Keller, M, Hanley, PJ, Simon, G, Nixon, DF, Hardy, D, Jones, RB & Bollard, CM 2020, 'HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform', Molecular Therapy Methods and Clinical Development, vol. 16, pp. 11-20. https://doi.org/10.1016/j.omtm.2019.10.001

@article{b6d47becc80c4c7cba92f080b3cba74d,

title = "HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform",

keywords = "conserved epitopes, HIV-specific T cells, immunotherapy, latent reservoir, viral escape",

author = "Shabnum Patel and Ryo Hanajiri and Melanie Grant and Devin Saunders and \{Van Pelt\}, Stacey and Michael Keller and Hanley, \{Patrick J.\} and Gary Simon and Nixon, \{Douglas F.\} and David Hardy and Jones, \{R. Brad\} and Bollard, \{Catherine M.\}",

note = "Publisher Copyright: {\textcopyright} 2019 The Author(s)",

year = "2020",

month = mar,

day = "13",

doi = "10.1016/j.omtm.2019.10.001",

language = "English",

volume = "16",

pages = "11--20",

journal = "Molecular Therapy Methods and Clinical Development",

issn = "2329-0501",

publisher = "Cell Press",

}

TY - JOUR

T1 - HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

AU - Patel, Shabnum

AU - Hanajiri, Ryo

AU - Grant, Melanie

AU - Saunders, Devin

AU - Van Pelt, Stacey

AU - Keller, Michael

AU - Hanley, Patrick J.

AU - Simon, Gary

AU - Nixon, Douglas F.

AU - Hardy, David

AU - Jones, R. Brad

AU - Bollard, Catherine M.

PY - 2020/3/13

Y1 - 2020/3/13

KW - conserved epitopes

KW - HIV-specific T cells

KW - immunotherapy

KW - latent reservoir

KW - viral escape

UR - https://www.scopus.com/pages/publications/85074012588

UR - https://www.scopus.com/pages/publications/85074012588#tab=citedBy

U2 - 10.1016/j.omtm.2019.10.001

DO - 10.1016/j.omtm.2019.10.001

M3 - Article

AN - SCOPUS:85074012588

SN - 2329-0501

VL - 16

SP - 11

EP - 20

JO - Molecular Therapy Methods and Clinical Development

JF - Molecular Therapy Methods and Clinical Development

ER -

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this